Fulgent Genetics Inc
NASDAQ:FLGT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Fulgent Genetics Inc
Fulgent Genetics Inc
Accrued Liabilities
Fulgent Genetics Inc
Accrued Liabilities Peer Comparison
DVA
DGX
CVS
CI
LH
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Accrued Liabilities
$25.9m
|
CAGR 3-Years
302%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Accrued Liabilities
$1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accrued Liabilities
$153m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Accrued Liabilities
$24.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Cigna Corp
NYSE:CI
|
Accrued Liabilities
$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accrued Liabilities
$820.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
See Also
What is Fulgent Genetics Inc's Accrued Liabilities?
Accrued Liabilities
25.9m
USD
Based on the financial report for Mar 31, 2024, Fulgent Genetics Inc's Accrued Liabilities amounts to 25.9m USD.
What is Fulgent Genetics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
72%
Over the last year, the Accrued Liabilities growth was 23%. The average annual Accrued Liabilities growth rates for Fulgent Genetics Inc have been 302% over the past three years , 72% over the past five years .
You don't have any saved screeners yet
